pSivida Corp. Share Price Nasdaq

Stocks

09/16/09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
14/16/14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
02/16/02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
28/15/28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
14/15/14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-0.70%	-4.28%	+52.62%	+86.42%	7.15TCr
ARGENX SE	+0.45%	-0.82%	+38.81%	+84.19%	6.01TCr
WUXI BIOLOGICS (CAYMAN) INC.	+4.86%	+6.34%	+37.02%	+26.32%	2.8TCr
INSMED INCORPORATED	-1.73%	-4.30%	-18.37%	+357.94%	2.53TCr
BIONTECH SE	-0.51%	-2.28%	+0.48%	-9.27%	2.48TCr
GENMAB A/S	+0.65%	+1.67%	+26.47%	-7.62%	2.1TCr
PHARMAESSENTIA CORPORATION	+3.46%	+3.02%	+158.90%	+337.81%	1.55TCr
EXELIXIS, INC.	+0.48%	+0.86%	+44.56%	+168.42%	1.45TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.47%	+1.28%	-4.82%	+522.39%	1.44TCr
Average	+0.96%	-0.79%	+37.30%	+174.07%	3.06TCr
Weighted average by Cap.	+0.66%	-1.52%	+37.38%	+130.32%